Cargando…
Training and validation of a novel 4-miRNA ratio model (MiCaP) for prediction of postoperative outcome in prostate cancer patients
BACKGROUND: New molecular biomarkers for prostate cancer (PC) prognosis are urgently needed. Ratio-based models are attractive, as they require no additional normalization. Here, we train and independently validate a novel 4-miRNA prognostic ratio model for PC. PATIENTS AND METHODS: By genome-wide m...
Autores principales: | Schmidt, L, Fredsøe, J, Kristensen, H, Strand, S H, Rasmussen, A, Høyer, S, Borre, M, Mouritzen, P, Ørntoft, T, Sørensen, K D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6158759/ https://www.ncbi.nlm.nih.gov/pubmed/30010760 http://dx.doi.org/10.1093/annonc/mdy243 |
Ejemplares similares
-
Validation of the four-miRNA biomarker panel MiCaP for prediction of long-term prostate cancer outcome
por: Strand, Siri H., et al.
Publicado: (2020) -
Aberrant DOCK2, GRASP, HIF3A and PKFP Hypermethylation has Potential as a Prognostic Biomarker for Prostate Cancer
por: Bjerre, Marianne T., et al.
Publicado: (2019) -
Novel diagnostic and prognostic classifiers for prostate cancer identified by genome-wide microRNA profiling
por: Kristensen, Helle, et al.
Publicado: (2016) -
Profiling of Circulating microRNAs in Prostate Cancer Reveals Diagnostic Biomarker Potential
por: Fredsøe, Jacob, et al.
Publicado: (2020) -
High miR-449b expression in prostate cancer is associated with biochemical recurrence after radical prostatectomy
por: Mortensen, Martin Mørck, et al.
Publicado: (2014)